Completed
Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy
NCT05794139
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
- Locations
-
- UCLA David Geffen School Of Medicine - Neurology Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- University of Kansas Medical Center Kansas City, Kansas, United States
- The Johns Hopkins Medicine, Spinal Muscular Atrophy Center Baltimore, Maryland, United States